1. Home
  2. AMSS vs RGNT Comparison

AMSS vs RGNT Comparison

Compare AMSS & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMASS Brands Inc. Common Stock

AMSS

AMASS Brands Inc. Common Stock

N/A

Current Price

$1.56

Market Cap

30.6M

ML Signal

N/A

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$3.69

Market Cap

24.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMSS
RGNT
Founded
N/A
2004
Country
United States
Israel
Employees
N/A
8
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.6M
24.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMSS
RGNT
Price
$1.56
$3.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
156.7K
10.4M
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$1.23
52 Week High
$2.44
$15.50

Technical Indicators

Market Signals
Indicator
AMSS
RGNT
Relative Strength Index (RSI) 39.11 51.16
Support Level N/A $3.02
Resistance Level $2.44 $4.54
Average True Range (ATR) 0.22 0.48
MACD -0.05 -0.12
Stochastic Oscillator 12.50 27.56

Price Performance

Historical Comparison
AMSS
RGNT

About AMSS AMASS Brands Inc. Common Stock

Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: